Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
15-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #3.8
advertisement
3.8 Pharmacology
(15)
Showing records 1 to 15
Display all abstracts in classification
3.8 Pharmacology
Search within classification 3.8 Pharmacology
55444
Epithelial mesenchymal transition-like phenomenon in trabecular meshwork cells
Takahashi E; Inoue T; Fujimoto T; Kojima S; Tanihara H
Experimental Eye Research
2014; 118: 72-79
55122
Cellular fibronectin expression in human trabecular meshwork and induction by transforming growth factor-β2
Medina-Ortiz WE; Belmares R; Neubauer S; Wordinger RJ; Clark AF
Investigative Ophthalmology and Visual Science
2013; 54: 6779-6788
55573
Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility
Dismuke WM; Liang J; Overby DR; Stamer WD
Experimental Eye Research
2014; 120: 28-35
55477
Control of outflow resistance by soluble adenylyl cyclase
Lee YS; Marmorstein AD
Journal of Ocular Pharmacology and Therapeutics
2014; 30: 138-142
55616
Exploring the potential mechanism and screening small molecule drugs for glaucoma by using bioinformatics approach
Liao Q; Sun XY; Guo H; Li C
European review for medical and pharmacological sciences
2014; 18: 132-140
55754
Oxidative stress and its downstream signaling in aging eyes
Pinazo-Durán MD; Gallego-Pinazo R; García-Medina JJ; Zanón-Moreno V; Nucci C; Dolz-Marco R; Martínez-Castillo S; Galbis-Estrada C; Marco-Ramírez C; López-Gálvez MI; Galarreta DJ; Díaz-Llópis M
Clinical Interventions in Aging
2014; 9: 637-652
55720
Antioxidant therapy for retinal disease
Kiang AS; Humphries MM; Campbell M; Humphries P
Adv Exp Med Biol
2014; 801: 783-789
55420
Ligands for glaucoma-associated myocilin discovered by a generic binding assay
Orwig SD; Chi PV; Du Y; Hill SE; Cavitt MA; Suntharalingam A; Turnage KC; Dickey CA; France S; Fu H; Lieberman RL
ACS Chemical Biology
2014; 9: 517-525
55480
Ocular hypotensive efficacy of Src-family tyrosine kinase inhibitors via different cellular actions from Rock inhibitors
Kirihara T; Shimazaki A; Nakamura M; Miyawaki N
Experimental Eye Research
2014; 119: 97-105
55505
General substance classification and pharmacology of glaucoma
Thieme H; Renieri G; Schuart C
Ophthalmologe
2013; 110: 1149-1154
55121
Delta-opioid receptors attenuate TNF-α-induced MMP-2 secretion from human ONH astrocytes
Akhter N; Nix M; Abdul Y; Singh S; Husain S
Investigative Ophthalmology and Visual Science
2013; 54: 6605-6611
55433
The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease
Giese MJ; Speth RC
Pharmacology and Therapeutics
2014; 142: 11-32
55693
Down-regulation of the RNA editing enzyme ADAR2 contributes to RGC death in a mouse model of glaucoma
Wang AL; Carroll RC; Nawy S
PLoS ONE
2014; 9: e91288
55250
Glaucoma and the applications of carbonic anhydrase inhibitors
Scozzafava A; Supuran CT
Sub-cellular biochemistry
2014; 75: 349-359
55719
Nipradilol Promotes Axon Regeneration Through S-Nitrosylation of PTEN in Retinal Ganglion Cells
Koriyama Y; Kamiya M; Arai K; Sugitani K; Ogai K; Kato S
Adv Exp Med Biol
2014; 801: 751-757
Issue
15-4
Table of Contents
Editor's Selection
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement